Northstar Distribution Center Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Northstar Distribution Center Pharmaceutical Import Records from India — 4 Products, $3.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Northstar Distribution Center — Pharmaceutical Importer Profile (2026) | 4 Products, $3.4M Trade | TransData Nexus

Northstar Distribution Center

Pharmaceutical Importer · United States · Analgesics & Antipyretics Focus · $3.4M Total Trade · DGFT Verified

Northstar Distribution Center is a pharmaceutical importer based in United States with a total trade value of $3.4M across 4 products in 4 therapeutic categories. Based on 68 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Northstar Distribution Center sources from 22 verified Indian suppliers, with Aurobindo Pharma Limited accounting for 23.4% of imports.

Northstar Distribution Center — Import Portfolio & Supplier Network

Northstar Distribution Center import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Northstar Distribution Center?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Aurobindo Pharma Limited	$36.3M	1,584	23.4%
Glenmark Pharmaceuticals Limited	$18.6M	504	12.0%
Dr.reddy's Laboratories Limited

What Formulations Does Northstar Distribution Center Import?

Formulation	Value	Ships
Levetiracetam oral solution USP 100MG/ML	$1.4M	28
Propofol INJ emu 1% (1000MG/100ML) x	$1.1M	22
Pharmaceutical medicine for human use	$1.0M	25
Propofol INJ emu 1% (200MG/20ML) x 20	$850.0K	17
Esomeprazole magnesium dr capsules USP	$808.8K	26
Ondansetron hcl tablets 4MG	$722.6K	20
Amoxicillin and clavulanate potassium	$700.2K	29
Pharmaceutical medicine for human use	$696.0K	20
Levetiracetam oral solution USP 100MG/ML, 473ML	$674.7K	16
Pharmaceuticals- rosuvastatin TAB 10MG	$554.3K	13
Propofol INJ emul1%(200MG/20ML)x10 ns	$550.0K	11
Drug&pha.harmles med-triamcinolone	$548.2K	27
(440044011) hydroxyzine hydrochloride	$522.2K	15
Pharmaceuticals- rosuvastatin TAB 20MG 90	$504.8K	11
Pharmaceutical medicine for human use	$492.7K	13

Northstar Distribution Center imports 3,220 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ketorolac	Analgesics & Antipyretics	$1.9M	39	1.7%	12
2	Furosemide	Diuretics	$1.2M	24	1.7%	12
3	Mesalamine	Gastrointestinal	$150.0K	3	0.0%	9
4	Digoxin	Cardiovascular	$57.1K	2	2.6%	5

Northstar Distribution Center imports 4 pharmaceutical products across 4 categories into United States totaling $3.4M.

Northstar Distribution Center — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Northstar Distribution Center is a U.S.-based pharmaceutical importer specializing in the acquisition and distribution of finished pharmaceutical formulations. Headquartered in Memphis, Tennessee, the company operates as a key player in the U.S. pharmaceutical supply chain, sourcing a diverse range of pharmaceutical products from international markets, particularly India. Their operations encompass the procurement, warehousing, and distribution of pharmaceutical goods to various healthcare providers across the United States.

The company has established a significant presence in the pharmaceutical import sector, with a total import value of $3.4 million USD from India over 68 shipments. Their product portfolio includes four distinct therapeutic categories, reflecting a strategic approach to meeting diverse healthcare needs. Notably, Northstar Distribution Center's top five imported products—Ketorolac, Furosemide, Mesalamine, and Digoxin—collectively account for 100% of their pharmaceutical imports, indicating a focused sourcing strategy.

2Distribution Network

Northstar Distribution Center operates a centralized distribution facility located at 4853 Crumpler Road, Memphis, Tennessee 38141, United States. This strategic location serves as the primary hub for their warehousing and logistics operations, facilitating efficient handling and distribution of pharmaceutical products. The facility is equipped to manage high-volume import shipments, ensuring timely delivery to various healthcare providers across the United States. While specific details about additional warehouse locations or logistics capabilities are not publicly disclosed, the Memphis facility's strategic positioning suggests a focus on optimizing supply chain efficiency within the U.S. market.

3Industry Role

In the U.S. pharmaceutical supply chain, Northstar Distribution Center functions primarily as a pharmaceutical importer and distributor. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company plays a crucial role in ensuring the availability of a diverse range of medications to meet the needs of healthcare providers and patients. Their operations bridge the gap between international pharmaceutical manufacturers and the U.S. healthcare system, contributing to the accessibility and affordability of essential medications.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Northstar Distribution Center

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Northstar Distribution Center's sourcing strategy exhibits a high degree of concentration, with the top five imported products—Ketorolac, Furosemide, Mesalamine, and Digoxin—accounting for 100% of their pharmaceutical imports. This singular focus on a limited product range suggests a strategic decision to specialize in specific therapeutic areas, potentially leveraging expertise and operational efficiencies. However, such concentration also introduces risks associated with dependency on a narrow product line, including exposure to market fluctuations and regulatory changes affecting these specific medications. The stability of their supplier relationships, as indicated by the consistent import volumes over time, suggests a well-established and reliable sourcing network.

2Supply Chain Resilience

The resilience of Northstar Distribution Center's supply chain is closely tied to the stability and reliability of their Indian suppliers. With a total of 22 unique suppliers, the company demonstrates a diversified sourcing approach, which can mitigate risks associated with single-source dependency. The consistent import volumes and the diversity of suppliers indicate a robust and adaptable supply chain capable of maintaining continuity in the face of potential disruptions. However, the company's reliance on a limited number of therapeutic categories may expose them to risks if market dynamics shift or if there are regulatory changes affecting these specific products.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth the legal framework for the importation, distribution, and marketing of drugs within the U.S. This legislation mandates that all drugs imported into the U.S. must be safe, effective, and manufactured in compliance with FDA regulations. The FDA's role includes reviewing and approving drug applications, conducting inspections of manufacturing facilities, and ensuring that imported drugs meet the required standards for quality and labeling.

2Import Licensing & GMP

Importers of pharmaceutical products into the United States must adhere to specific licensing requirements set forth by the FDA. This includes obtaining an FDA registration number and ensuring that all imported drugs are listed with the FDA. Additionally, the FDA requires that foreign manufacturing facilities comply with Good Manufacturing Practice (GMP) standards. While the FDA does not directly recognize certifications such as EU GMP, WHO GMP, or PIC/S, it conducts its own inspections to verify compliance with GMP standards. Importers must ensure that their foreign suppliers meet these standards to facilitate the admissibility of their products into the U.S. market.

Northstar Distribution Center — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Northstar Distribution Center's product strategy focuses on four therapeutic categories: Analgesics & Antipyretics, Diuretics, and Gastrointestinal medications. This selection aligns with the company's import portfolio, which includes products like Ketorolac (Analgesics & Antipyretics), Furosemide (Diuretics), Mesalamine (Gastrointestinal), and Digoxin (Gastrointestinal). The choice of these categories suggests a strategic focus on addressing common and critical health conditions, ensuring a steady demand for these medications. Market demand for these therapeutic areas is driven by the prevalence of conditions such as pain, hypertension, heart failure, and gastrointestinal disorders, necessitating a reliable supply of effective treatments.

2Sourcing Profile

Northstar Distribution Center's sourcing strategy emphasizes the procurement of generic pharmaceutical drugs, primarily in finished dosage forms such as tablets, capsules, syrups, and injections. This approach allows the company to offer cost-effective alternatives to brand-name medications, catering to a broad segment of the U.S. healthcare market. India's well-established pharmaceutical manufacturing industry, known for its compliance with international quality standards, makes it a preferred sourcing destination for Northstar. By leveraging India's manufacturing capabilities, Northstar can ensure a consistent supply of high-quality generic medications to meet the needs of U.S. healthcare providers and patients.

Seller's Guide — How to Become a Supplier to Northstar Distribution Center

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian pharmaceutical suppliers to partner with Northstar Distribution Center. The company's focus on specific therapeutic categories and its reliance on a limited number of products suggest potential gaps in their current sourcing strategy. Indian exporters can capitalize on this by offering high-quality generic medications in these therapeutic areas, ensuring compliance with FDA regulations and meeting the necessary quality standards. Establishing strong relationships with Northstar can lead to mutually beneficial partnerships, expanding the range of products available to U.S. healthcare providers and patients.

2Requirements & Qualifications

Indian pharmaceutical exporters seeking to supply Northstar Distribution Center and the U.S. market must ensure that their products comply with FDA regulations. This includes obtaining FDA approval for their drug products, ensuring that manufacturing facilities adhere to Good Manufacturing Practice (GMP) standards, and providing labeling that meets FDA requirements. Additionally, exporters must be prepared to navigate the FDA's import procedures, which involve filing entry notices and bonds with U.S. Customs and Border Protection, and may include FDA inspections and sample analyses to verify compliance.

Frequently Asked Questions — Northstar Distribution Center

What products does Northstar Distribution Center import from India?

Northstar Distribution Center imports 4 pharmaceutical products across 4 categories. Top imports: Ketorolac ($1.9M), Furosemide ($1.2M), Mesalamine ($150.0K), Digoxin ($57.1K).

Who supplies pharmaceuticals to Northstar Distribution Center from India?

Northstar Distribution Center sources from 22 verified Indian suppliers. The primary supplier is Aurobindo Pharma Limited (23.4% of imports, $36.3M).

What is Northstar Distribution Center's total pharmaceutical import value?

Northstar Distribution Center's total pharmaceutical import value from India is $3.4M, based on 68 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Northstar Distribution Center focus on?

Northstar Distribution Center imports across 4 categories. The largest: Analgesics & Antipyretics (58.1%), Diuretics (35.7%), Gastrointestinal (4.5%).

Get Full Northstar Distribution Center Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Northstar Distribution Center

Northstar Distribution Center — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Northstar Distribution Center?

What Formulations Does Northstar Distribution Center Import?

What Products Does Northstar Distribution Center Import?

Top Products by Import Value

Northstar Distribution Center Therapeutic Categories — 4 Specializations